Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Procaterol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 16/20 | 1.00 |
| ▸ | ADRB1 | P08588 | 9/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | DRD2 | P14416 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 0.98 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.98 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.98 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Procaterol SCHEMBL30505289 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL29390065 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL28926423 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL14012960 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL29445557 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL4632 | 1.00 | ADRB2 (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL124726 | 0.99 | KDM4E (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL29992718 | 0.99 | KDM4E (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL9737339 | 0.99 | KDM4E (1.00) | ADRB2ADRB1KDM4EMEN1LMNA | |
| Procaterol SCHEMBL29832201 | 0.99 | KDM4E (1.00) | ADRB2ADRB1KDM4EMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11034 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106796-A1 | SYSTEM AND METHOD FOR THE TREATMENT OF TELOGEN EFFLUVIUM, ANDROGENETIC ALOPECIA, AND OTHER HAIR LOSS DISORDERS | FOLLEA INTERNATIONAL (US) | 2026-05-21 | — | — | WO | claimed |
| US-20260132115-A1 | SUBSTITUTED 3-FLUOROBENZENEPROPANOATE COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | TIANJIN GUDUI BIO PHARM CO LTD (CN) | 2026-05-14 | — | — | US | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4722714-A1 | SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) | Korea Institute of Science and Technology (KR) | 2026-04-08 | — | — | EP | claimed |
| EP-4434588-B1 | AEROSOL DELIVERY DEVICE | PARI PHARMA GMBH (DE) | 2026-04-08 | — | — | EP | claimed |
| US-12545948-B2 | Identification of novel loci in asthma and methods of use thereof for the diagnosis and treatment of asthma | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2026-02-10 | — | — | US | claimed |
| WO-2025265094-A1 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-26 | — | — | WO | claimed |
| EP-4600244-A1 | SUBSTITUTED 3-FLUOROBENZENEPROPANOATE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITIONS, AND USES | Tianjin Gudui Bio-Pharm Co., Ltd. (CN) | 2025-08-13 | — | — | EP | claimed |
| US-20250213647-A1 | CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE | UNIVERSITY OF SOUTH FLORIDA | 2025-07-03 | — | — | US | claimed |
| US-20250195624-A1 | USE OF SUPEROXIDE DISMUTASE FOR THE TREATMENT AND/OR PREVENTION OF ALLERGIC ASTHMA | Isocell S.A.S. (FR) | 2025-06-19 | — | — | US | claimed |
| US-4778673-A | THERAPEUTIC OR PROPHYLACTIC ACTION TO PREVENT OR NEUTRALIZE IRRITATION OF RESPIRATORY TRACT MUCOSAE; TERPENES; ODORS | OECE INDUSTRIE CHIMICHE SPA (IT) | 1988-10-18 | — | — | US | claimed |
| EP-0264951-A2 | Process for stabilising procaterol | WARNER-LAMBERT COMPANY (US) | 1988-04-27 | — | — | EP | claimed |
| EP-0258356-A1 | NEW PHARMACEUTICAL COMPOSITIONS FOR INHALATION. | CHIESI FARMA SPA (IT) | 1988-03-09 | — | — | EP | claimed |
| WO-1987005803-A1 | COMPOSITIONS OF LIPOSOMES AND beta2-RECEPTOR ACTIVE SUBSTANCES | AKTIEBOLAGET DRACO (SE) | 1987-10-08 | — | — | WO | claimed |
| EP-0239798-A1 | New pharmaceutical compositions for inhalation | CHIESI FARMACEUTICI S.p.A. (IT) | 1987-10-07 | — | — | EP | claimed |
| WO-1987005213-A1 | NEW PHARMACEUTICAL COMPOSITIONS FOR INHALATION | CHIESI FARMACEUTICI S.P.A. (IT) | 1987-09-11 | — | — | WO | claimed |
| US-4687776-A | FORMING DERIVATIVES OF PROCATEROL | WARNER-LAMBERT COMPANY (US) | 1987-08-18 | — | — | US | claimed |
| US-4616022-A | WITH MONOVALENT METAL OR AMMONIUM SALT OF LAURYL SULFATE | WARNER-LAMBERT COMPANY (US) | 1986-10-07 | — | — | US | claimed |
| EP-0171969-A2 | Procaterol stabilization | WARNER-LAMBERT COMPANY (US) | 1986-02-19 | — | — | EP | claimed |
| EP-0167825-A2 | Lipid nano pellets as drug carriers for oral administration | Dr. Rentschler Arzneimittel GmbH & Co. (DE) | 1986-01-15 | — | — | EP | claimed |